Dina Khalaf

Associate Professor

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dina Khalaf is an Associate Professor at MUSC Hollings Cancer Center in the United States. Her research focuses on hematologic malignancies, with a particular emphasis on allogeneic stem cell transplantation, acute myeloid leukemia, and patient care perceptions in oncology. Recent publications highlight her work on prognostic indicators, therapeutic strategies, and the biological mechanisms underlying treatments for these complex conditions.

Articles (12)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (4)

Donald Arnold

Professor

McMaster University

CANADA

View details

Kathryn Webert

McMaster University

CANADA

View details

Dawn Maze

Assistant Professor

University of Toronto

CANADA

View details

Hira Mian

CANADA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Dina Khalaf

Research Interests

Explore related searches

Contact this professor

About

Articles (12)

Outcomes of Allogeneic Stem Cell Transplant in Patients with Relapsed/Refractory Hodgkin Lymphoma

Early Mixed Donor Chimerism is a Strong Negative Prognostic Indicator in Allogeneic Stem Cell Transplant for AML and MDS

Healthcare provider's perceptions of bleeding in patients with acute leukaemia undergoing induction chemotherapy: A qualitative study

Concurrent BCR‐ABL1 and core binding factor beta rearrangement in de novo acute myeloid leukemia: A case report and review of literature

Preclinical characterization and clinical trial of CFI-400945, a polo-like kinase 4 inhibitor, in patients with relapsed/refractory acute myeloid leukemia and higher-risk myelodysplastic neoplasms

Cardiac Interventions in Patients With Active, Advanced Solid and Hematologic Malignancies JACC: CardioOncology State-of-the-Art Review

Analysis of the Impact of Whole Blood and T-Cell Donor Chimerism after Allogeneic Stem Cell Transplant

Concurrent BCR::-ABL1 and CBFB Rearrangement in De Novo Acute Myeloid Leukemia

LSD1 Inhibition Enhances Antigen Presentation and Co-Stimulation in AML to Promote T Cell-Mediated Anti-Leukemia Immune Responses

LSD1 Inhibition Synergizes with Venetoclax in Acute Myeloid Leukemia By Targeting Cellular Metabolism

Ureaplasma-Induced Hyperammonemia Syndrome - an Acute Complication Post Allogeneic Stem Cell Transplant

Cardiovascular events among recipients of hematopoietic stem cell transplantation-A systematic review and meta-analysis

Collaborators (4)

Donald Arnold

Kathryn Webert

Dawn Maze

Hira Mian

Make your next move.